People · Operator
Named in public records as an officer, director or promoter · active 2010–2014 · Biotechnology, Manufacturing, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Edison Pharmaceuticals Inc | — | Biotechnology | Series C | $80.2M | $2.0B | 2012 |
| VIA Motors, Inc. | — | Manufacturing | Series B | $59.7M | $31.7M | 2011 |
| Valence Technology Inc | — | Other Technology | Pre-Seed | $1.1M | $4.9M | 2010 |
Carl E. Berg at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Carl E. Berg on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Carl Berg | 2 | 3 |
| Isaac Cheng | 1 | 9 |
| Robert Lutz | 1 | 7 |
| Taro Inaba | 1 | 4 |
| David West | 1 | 4 |
| Forrest Sawyer | 1 | 2 |
| Richard Clayton | 1 | 2 |
| Pablo Acedo | 1 | 2 |
| Kraig Higginson | 1 | 2 |
| Guy Miller | 1 | 2 |
| Alan D Perriton | 1 | 2 |
| Richard D Clayton | 1 | 2 |
| Paul Avery | 1 | 2 |
| Alan G. Perriton | 1 | 2 |
| David D. Muir | 1 | 2 |
| John H. Weber | 1 | 2 |
| Robert D. Lutz | 1 | 2 |
| Alan Perriton | 1 | 1 |
| Dave Rapier | 1 | 1 |
| Martine Thoolen | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.